Cargando…

Does Sitagliptin Affect the Rate of Osteoporotic Fractures in Type 2 Diabetes? Population-Based Cohort Study

CONTEXT: Type 2 diabetes and osteoporosis are both common, chronic, and increase with age, whereas type 2 diabetes is also a risk factor for major osteoporotic fractures (MOFs). However, different treatments for type 2 diabetes can affect fracture risk differently, with metaanalyses showing some age...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majumdar, Sumit R., Josse, Robert G., Lin, Mu, Eurich, Dean T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870843/ https://www.ncbi.nlm.nih.gov/pubmed/26930183 http://dx.doi.org/10.1210/jc.2015-4180

Ejemplares similares

Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study
por: Eurich, D T, et al.
Publicado: (2013)

Population-based cohort study of outpatients with pneumonia: rationale, design and baseline characteristics
por: Eurich, Dean T, et al.
Publicado: (2012)

Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study
por: Lau, Darren, et al.
Publicado: (2013)

Rates of, and risk factors for, septic arthritis in patients with invasive pneumococcal disease: prospective cohort study
por: Marrie, Thomas J., et al.
Publicado: (2017)

Sitagliptin and Fractures in Type 2 Diabetes: A Nationwide Population-Based Propensity-Matching Study
por: Lin, Shih-Yi, et al.
Publicado: (2018)

Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis
por: Chen, Christopher B., et al.
Publicado: (2018)

Does time-to-surgery affect mortality in patients with acute osteoporotic vertebral compression fractures?
por: Pfeifle, Christian, et al.
Publicado: (2021)

Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks
por: Eurich, Dean T, et al.
Publicado: (2011)

Incidence rate of osteoporotic hip fracture in Qatar
por: Alsaed, Omar Suhail, et al.
Publicado: (2021)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur?
por: Cho, Yoon Je, et al.
Publicado: (2015)

Presence of sarcopenia does not affect the clinical results of balloon kyphoplasty for acute osteoporotic vertebral fracture
por: Ohyama, Shoichiro, et al.
Publicado: (2021)

Effect of sitagliptin on proteinuria in patients with type 2 diabetes – A renoprotective effect of sitagliptin
por: Narimani, Rouhollah, et al.
Publicado: (2021)

Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures
por: Aypak, Cenk, et al.
Publicado: (2022)

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
por: Smits, Mark M., et al.
Publicado: (2016)

The effect of type 2 diabetes mellitus on the prognosis of osteoporotic vertebral compression fracture with osteoporotic fracture classification after vertebroplasty
por: Wang, Zixiang, et al.
Publicado: (2023)

Sarcopenia affects conservative treatment of osteoporotic vertebral fracture
por: Iida, Hiroki, et al.
Publicado: (2018)

Prognostic factors associated with mortality and major in-hospital complications in patients with bacteremic pneumococcal pneumonia: Population-based study
por: Beatty, Jessica A., et al.
Publicado: (2016)

Osteoporotic fracture rates in chronic hemodialysis and effect of heparin exposure: a retrospective cohort study
por: Harrak, Hind, et al.
Publicado: (2020)

Addressing the gaps in diabetes care in first nations communities with the reorganizing the approach to diabetes through the application of registries (RADAR): the project protocol
por: Eurich, Dean T., et al.
Publicado: (2017)

The Association of Metabolic Syndrome and Obesity With Clinical Hip Osteoarthritis in the Study of Osteoporotic Fractures and the Osteoporotic Fractures in Men Study Cohorts
por: Cheng, Karen Y., et al.
Publicado: (2023)

Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments
por: Marrie, T. J., et al.
Publicado: (2017)

Pancreatic Safety of Sitagliptin in the TECOS Study
por: Buse, John B., et al.
Publicado: (2017)

Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis
por: Kim, Seo Young, et al.
Publicado: (2010)

Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus
por: Liu, Hongyan, et al.
Publicado: (2022)

Evaluation of easily measured risk factors in the prediction of osteoporotic fractures
por: Bensen, Robert, et al.
Publicado: (2005)

Sitagliptin and risk of heart failure hospitalization in patients with type 2 diabetes on dialysis: A population-based cohort study
por: Hung, Yi-Chih, et al.
Publicado: (2016)

The durability of sitagliptin in elderly patients with type 2 diabetes
por: Hsieh, Ching-Jung, et al.
Publicado: (2014)

Concurrent Infection with Hepatitis C Virus and Streptococcus pneumoniae
por: Marrie, Thomas J., et al.
Publicado: (2017)

Age Is Just a Number: Patient Age Does Not Affect Outcome Following Surgery for Osteoporotic Vertebral Compression Fractures
por: Gupta, Anmol, et al.
Publicado: (2020)

Does the Prediction Accuracy of Osteoporotic Fractures by BMD and Clinical Risk Factors Vary With Fracture Site?
por: Iconaru, L, et al.
Publicado: (2019)

Quality of life and factors that affect osteoporotic hip fracture patients in Thailand
por: Amphansap, Tanawat, et al.
Publicado: (2018)

Total Cholesterol Variability and the Risk of Osteoporotic Fractures: A Nationwide Population-Based Cohort Study
por: Kim, Dongyeop, et al.
Publicado: (2023)

Cardiovascular Outcomes of Sitagliptin in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Population-Based Cohort Study in Taiwan
por: Wang, Szu-Heng, et al.
Publicado: (2015)

Sitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study
por: Chen, Dong-Yi, et al.
Publicado: (2015)

Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up
por: Eurich, Dean T, et al.
Publicado: (2017)

Risk of Fractures, Repeated Fractures and Osteoporotic Fractures among Patients with Hemophilia in Taiwan: A 14-Year Population-Based Cohort Study
por: Pai, Yuan-Yi, et al.
Publicado: (2022)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
por: Miller, Shannon A, et al.
Publicado: (2009)

Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus
por: Mori, Hiroko, et al.
Publicado: (2013)

Efficacy and Safety of Sitagliptin in Japanese Patients With Type 2 Diabetes
por: Ohmura, Hirotoshi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mj9iaf7nku2g19gm3i82vg85te